SELÇUK YÜKSEL

Prof. SELÇUK YÜKSEL

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2019 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
SLSergio Camilo Lopez-Garcia
Sergio Camilo Lopez-Garcia
FEFrancesco Emma
Francesco Emma
SWStephen B Walsh
Stephen B Walsh
MFMarc Fila
Marc Fila
NHNakysa Hooman
Nakysa Hooman
DBDetlef Bockenhauer
Detlef Bockenhauer
Primary distal renal tubular acidosis (dRTA) is a rare disorder, and we aimed to gather data on treatment and long-term outcome. We contacted paediatric and adult nephrologists through European professional organizations. Responding clinicians entered demographic, biochemical, genetic and clinical data in an online form. Adequate data were collected on 340 patients (29 countries, female 52%). Mutation testing had been performed on 206 patients (61%); pathogenic mutations were identified in 170 patients (83%). The median (range) presentation age was 0.5 (0-54) years and age at last follow-up was 11.0 (0-70.0) years. Adult height was slightly below average with a mean (SD score) of -0.57 (±1.16). There was an increased prevalence of chronic kidney disease (CKD) Stage ≥2 in children (35%) and adults (82%). Nephrocalcinosis was reported in 88%. Nephrolithiasis was more common with SLC4A1 mutations (42% versus 21%). Thirty-six percent had hearing loss, particularly in ATP6V1B1 (88%). The median (interquartile range) prescribed dose of alkali (mEq/kg/day) was 1.9 (1.2-3.3). Adequate metabolic control (normal plasma bicarbonate and normocalciuria) was achieved in 158 patients (51%), more commonly in countries with higher gross domestic product (67% versus 23%), and was associated with higher height and estimated glomerular filtration rate. Long-term follow-up from this large dRTA cohort shows an overall favourable outcome with normal adult height for most and no patient with CKD Stage 5. However, 82% of adult patients have CKD Stages 2-4. Importance of adequate metabolic control was highlighted by better growth and renal function but was achieved in only half of patients.

1 November 2006 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
SYSELÇUK YÜKSEL
SELÇUK YÜKSEL
BHBurcu Ozturk Hismi
Burcu Ozturk Hismi
AKAslı Kavaz
Aslı Kavaz
ZÖZeynep Birsin Özçakar
Zeynep Birsin Özçakar
BABanu Acar
Banu Acar
FYFatoş Yalçınkaya
Fatoş Yalçınkaya


19 February 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
IKIlker Karacan
Ilker Karacan
ABAyşe Balamir
Ayşe Balamir
SUSerdal Uğurlu
Serdal Uğurlu
AAAsli Kirectepe Aydin
Asli Kirectepe Aydin
EEElif Everest
Elif Everest
ETEda Tahir Turanli
Eda Tahir Turanli

1 December 2014 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
SYSELÇUK YÜKSEL
SELÇUK YÜKSEL
AYAyşe Çolpan Yurdakul
Ayşe Çolpan Yurdakul
MZMehmet Zencir
Mehmet Zencir
NÇNergül Çördük
Nergül Çördük

1 March 2006 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ZÖZeynep Birsin Özçakar
Zeynep Birsin Özçakar
FYFaros Yalçinkaya
Faros Yalçinkaya
SYSELÇUK YÜKSEL
SELÇUK YÜKSEL
BABanu Acar
Banu Acar
MEMesiha Ekim
Mesiha Ekim
DGDerya Gökmen
Derya Gökmen